Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2024 Earnings Call Transcript November 18, 2024
Cellectar Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.55 EPS, expectations were $-0.35.
Operator: Ladies and gentlemen, thank you for standing by. And welcome at this time, all participants are in listen only mode. Following the presentation, there will be a question-and-answer session. Please be advised that today’s conference call may be recorded. I would now like to hand...
